BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study is being done to determine the effects (good and bad) of intravenous infusion of a
human brain natriuretic peptide (BNP), Natrecor (nesiritide), a hormone produced by the heart
in persons who have just suffered a heart attack. The human BNP, Natrecor (nesiritide) has
been approved by the United States Food and Drug Administration (FDA) to be given
intravenously for the management of acute heart failure. It is unknown if human BNP may have
good effects on the pumping function of the heart after a heart attack.